We are live on ! Find out more
SK

Seth Klarman Baupost Group

AUM $5.42B
1-Year Est. Return 22.93%
 

Seth Klarman is the founder and CEO of the Baupost Group, one of the most respected value-oriented investment firms. He is the author of Margin of Safety and is known for patient, opportunistic capital allocation across equities, credit, and special situations. Klarman’s approach emphasizes downside protection, cash when opportunities are scarce, and independent thinking when markets become crowded.

This Fund
S&P 500
This Quarter Est. Return
+2.89%
1 Year Est. Return
+22.93%
3 Year Est. Return
+47.86%
5 Year Est. Return
+25.7%
10 Year Est. Return
+163.46%
AUM
$7.37B
AUM Growth
+$442M
Cap. Flow
+$320M
Cap. Flow %
4.34%
Top 10 Hldgs %
74.45%
Holding
44
New
10
Increased
5
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$228M
2
EMC
EMC CORPORATION
EMC
+$138M
3
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
+$93.8M
4
AGN
Allergan plc
AGN
+$64.6M
5
CAR icon
Avis
CAR
+$49.4M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$191M
2
PYPL icon
PayPal
PYPL
+$53.4M
3
BITI
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
+$36.8M
4
NG icon
NovaGold Resources
NG
+$32.8M
5
INVA icon
Innoviva
INVA
+$26.1M

Sector Composition

Rank Sector Weight
1 Technology 35.76%
2 Energy 24.26%
3 Healthcare 17.32%
4 Communication Services 6.28%
5 Financials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BATRK icon
26
Atlanta Braves Holdings Series B
BATRK
$3.33B
$43.9M 0.6%
+2,994,010
New +$44.6M
PR
27
Permian Resources
PR
$19.9B
$36.8M 0.5%
+3,750,000
New +$37.5M
PRTK
28
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$28.4M 0.39%
2,044,498
+500,000
+32% +$7.36M
CASC
29
DELISTED
Cascadian Therapeutics, Inc.
CASC
$23.6M 0.32%
+4,166,667
New +$28.3M
CACC icon
30
Credit Acceptance
CACC
$6.24B
$18.5M 0.25%
+100,000
New +$18.3M
RUN icon
31
Sunrun
RUN
$2.21B
$16.9M 0.23%
2,848,082
– –
SCU
32
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$12.8M 0.17%
+337,389
New +$13.1M
BATRA icon
33
Atlanta Braves Holdings Series A
BATRA
$3.64B
$12M 0.16%
+800,000
New +$12.3M
KIN
34
DELISTED
Kindred Biosciences, Inc.
KIN
$10.7M 0.14%
3,013,848
– –
OREX
35
DELISTED
Orexigen Therapeutics, Inc.
OREX
$9.57M 0.13%
2,226,840
– –
C.WS.A
36
DELISTED
Citigroup Inc
C.WS.A
$6.03M 0.08%
102,553,207
– –
TMQ
37
Trilogy Metals
TMQ
$684M
$5.3M 0.07%
10,600,758
– –
GNW icon
38
Genworth Financial
GNW
$3.73B
– –
-1,699,195
Closed -$4.64M
LQ
39
DELISTED
La Quinta Holdings Inc.
LQ
– –
-1,111,000
Closed -$13.9M
BXE
40
DELISTED
Bellatrix Exploration Ltd.
BXE
– –
-1,730,656
Closed -$8.74M
BITI
41
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
– –
-1,395,000
Closed -$36.8M
1
2

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $5.42B AUM 31.03% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $5.4B AUM 28.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $5.44B AUM 27.71% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $5.39B AUM 56.42% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $5.44B AUM 26.35% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return

Seth Klarman's Q2 2016 Portfolio in Review

As of Q2 2016, Seth Klarman held 44 positions worth $7.37B, up 6.4% from $6.92B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Seth Klarman deployed $320M of net new capital in Q2 2016, opening 10 new positions and adding to 5 existing holdings. Its largest new stake was Citigroup: 5,167,000 shares worth $219M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Antero Resources, an estimated $191M trimmed.

  • Seth Klarman's largest Q2 2016 buy was Citigroup: 5,167,000 shares worth $219M.
  • Seth Klarman added most to EMC CORPORATION in Q2 2016, an estimated $138M increase.
  • Seth Klarman's biggest Q2 2016 reduction was Antero Resources, cutting an estimated $191M.
  • Seth Klarman fully exited BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2016, selling an estimated $36.8M.
  • Seth Klarman's ten largest holdings make up 74% of its $7.37B portfolio in Q2 2016.
  • Seth Klarman opened 10 new positions and closed 5 in Q2 2016.
  • Seth Klarman's portfolio value rose 6.4% quarter-over-quarter to $7.37B.

Based on Baupost Group's 13F filing for Q2 2016, filed 12 Aug 2016.